BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38474258)

  • 1. Plasma Circulating mRNA Profile for the Non-Invasive Diagnosis of Colorectal Cancer Using NanoString Technologies.
    Tsang HF; Pei XM; Wong YKE; Wong SCC
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood RNA biomarker panel detects both left- and right-sided colorectal neoplasms: a case-control study.
    Chao S; Ying J; Liew G; Marshall W; Liew CC; Burakoff R
    J Exp Clin Cancer Res; 2013 Jul; 32(1):44. PubMed ID: 23876008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The non-invasive diagnosis of colorectal cancer via a SOX9-based gene panel.
    Xue VW; Ng SSM; Tsang HF; Wong HT; Leung WW; Wong YN; Wong YKE; Yu ACS; Yim AKY; Cho WCS; Tai WCS; Wong SCC
    Clin Exp Med; 2023 Oct; 23(6):2421-2432. PubMed ID: 36637582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
    Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
    Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel gene expression signature in peripheral blood mononuclear cells for early detection of colorectal cancer.
    Nichita C; Ciarloni L; Monnier-Benoit S; Hosseinian S; Dorta G; Rüegg C
    Aliment Pharmacol Ther; 2014 Mar; 39(5):507-17. PubMed ID: 24428642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer.
    Wang Q; Huang Z; Ni S; Xiao X; Xu Q; Wang L; Huang D; Tan C; Sheng W; Du X
    PLoS One; 2012; 7(9):e44398. PubMed ID: 22970209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating miRNAs and lncRNAs serve as biomarkers for early colorectal cancer diagnosis.
    Lotfi E; Kholghi A; Golab F; Mohammadi A; Barati M
    Pathol Res Pract; 2024 Mar; 255():155187. PubMed ID: 38377721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
    Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
    Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a 29-gene panel in peripheral blood mononuclear cells for the detection of colorectal cancer and adenomas using high throughput real-time PCR.
    Ciarloni L; Hosseinian S; Monnier-Benoit S; Imaizumi N; Dorta G; Ruegg C;
    PLoS One; 2015; 10(4):e0123904. PubMed ID: 25876024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A plasma microRNA panel for early detection of colorectal cancer.
    Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
    Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipeptidyl-peptidase IV activity is correlated with colorectal cancer prognosis.
    Larrinaga G; Perez I; Sanz B; Beitia M; Errarte P; Fernández A; Blanco L; Etxezarraga MC; Gil J; López JI
    PLoS One; 2015; 10(3):e0119436. PubMed ID: 25790122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-surface markers for colon adenoma and adenocarcinoma.
    Sewda K; Coppola D; Enkemann S; Yue B; Kim J; Lopez AS; Wojtkowiak JW; Stark VE; Morse B; Shibata D; Vignesh S; Morse DL
    Oncotarget; 2016 Apr; 7(14):17773-89. PubMed ID: 26894861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Colorectal Cancer Is Associated With Lower Disease Stage: A Population-Based Study.
    Kubisch CH; Crispin A; Mansmann U; Göke B; Kolligs FT
    Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1612-1618.e3. PubMed ID: 27085763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer.
    Rahier JF; Druez A; Faugeras L; Martinet JP; Géhénot M; Josseaux E; Herzog M; Micallef J; George F; Delos M; De Ronde T; Badaoui A; D'Hondt L
    Clin Epigenetics; 2017; 9():53. PubMed ID: 28515797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of Unbiased RNA Profiling of Colorectal Tumors: A Proof of Principle.
    Moshayoff V; Faktor O; Laghi L; Celesti G; Peretz T; Keret D; Cohen D; Israeli E
    PLoS One; 2016; 11(7):e0159522. PubMed ID: 27441409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma miRNA can detect colorectal cancer, but how early?
    Wikberg ML; Myte R; Palmqvist R; van Guelpen B; Ljuslinder I
    Cancer Med; 2018 May; 7(5):1697-1705. PubMed ID: 29573205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colonoscopy, Biomarkers, and Targeted Therapy in Colorectal Cancer.
    Effendi-Ys R
    Acta Med Indones; 2022 Jul; 54(3):476-486. PubMed ID: 36156476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of colorectal cancer screening participation in remote northern Canada: A retrospective cohort study.
    Smith HA; Scarffe AD; Brunet N; Champion C; Kandola K; Tessier A; Boushey R; Kuziemsky C
    World J Gastroenterol; 2020 Dec; 26(48):7652-7663. PubMed ID: 33505142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.